Chirag M. Acharya - Publications

AI-Driven Patient Education in Chronic Kidney Disease: Evaluating Chatbot Responses against Clinical Guidelines.

Journal: Diseases (Basel, Switzerland)

Published: June 18, 2024

Efficacy and Safety of Plasma Exchange as an Adjunctive Therapy for Rapidly Progressive IgA Nephropathy and Henoch-Schönlein Purpura Nephritis: A Systematic Review.

Journal: International journal of molecular sciences

Published: January 11, 2023

Feature Importance of Acute Rejection among Black Kidney Transplant Recipients by Utilizing Random Forest Analysis: An Analysis of the UNOS Database.

Journal: Medicines (Basel, Switzerland)

Published: August 31, 2021

Incidence and Characteristics of Kidney Stones in Patients on Ketogenic Diet: A Systematic Review and Meta-Analysis.

Journal: Diseases (Basel, Switzerland)

Published: April 24, 2021

APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications.

Journal: Leukemia

Published: May 07, 2018

Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: February 05, 2018

Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple Myeloma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 19, 2016

Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma.

Journal: Oncotarget

Published: May 06, 2016

Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication.

Journal: Blood

Published: March 28, 2016

Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenström Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation Status.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 10, 2016

APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment.

Journal: Blood

Published: January 14, 2016

Detection of recurrent cytogenetic aberrations in multiple myeloma: a comparison between MLPA and iFISH.

Journal: Oncotarget

Published: June 27, 2015